Compare ELAN & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | WLK |
|---|---|---|
| Founded | 1954 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.3B |
| IPO Year | 2018 | 2004 |
| Metric | ELAN | WLK |
|---|---|---|
| Price | $22.67 | $80.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | $27.89 | ★ $106.87 |
| AVG Volume (30 Days) | ★ 6.7M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.22 | ★ 0.70 |
| Revenue | $4,715,000,000.00 | ★ $11,170,000,000.00 |
| Revenue This Year | $8.21 | $5.51 |
| Revenue Next Year | $5.31 | $3.74 |
| P/E Ratio | ★ $100.55 | $112.77 |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $17.11 | $56.33 |
| 52 Week High | $27.98 | $124.23 |
| Indicator | ELAN | WLK |
|---|---|---|
| Relative Strength Index (RSI) | 37.30 | 58.20 |
| Support Level | $20.64 | $77.58 |
| Resistance Level | $23.16 | $90.28 |
| Average True Range (ATR) | 1.16 | 2.96 |
| MACD | -0.45 | 1.04 |
| Stochastic Oscillator | 21.62 | 91.52 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.